Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 9, 2021
Factors Influencing 1st and 2nd Generation Drug-Eluting Stent Performance: Understanding the Basic Pharmaceutical Drug-in-Polymer Formulation Factors Contributing to Stent Thrombosis Do We Really Need to Eliminate the Polymer?Iva SrdanovicJournal of Cannabis Research|June 20, 2024
Non-linear plasma protein binding of cannabidiolMariana Babayeva, Iva SrdanovicBlood|March 17, 2010
Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clonesIsabelle Isnardi, Yen-Shing Ng, Laurence Menard, et al.Coronary Artery Disease|May 19, 2021
Impact of renin-angiotensin system inhibitors after revascularization of patients with left main coronary artery diseaseShmuel Chen, Björn Redfors, Patrick W Serruys, et al.American Heart Journal|May 28, 2019
Incidence and predictors of target lesion failure in patients undergoing contemporary DES implantation-Individual patient data pooled analysis from 6 randomized controlled trialsMaayan Konigstein, Mahesh V Madhavan, Ori Ben-Yehuda, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 30, 2018
Outcomes of the Tryton-dedicated bifurcation stent for the treatment of true coronary bifurcations: Individual-patient-data pooled analysisMaayan Konigstein, Iva Srdanovic, Ankita K Gore, et al.Immunity|November 14, 2008
IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humansIsabelle Isnardi, Yen-Shing Ng, Iva Srdanovic, et al.Journal of the American Heart Association|December 24, 2022
On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two-Year Results From ADAPT-DESBahira Shahim, Björn Redfors, Thomas D Stuckey, et al.Pageof 1